Maine Medicine Weekly Update - Maine Medicine Weekly Update
October 18, 2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
LEAD STORY
•  FDA Advisory Committee Recommends Moderna, J&J Boosters. What You Need to Know
More COVID Guidance & News
•  Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds
•  Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients
•  FDA Schedules Advisory Committee Meeting to Discuss COVID-19 Oral Treatment
•  Federal COVID Vaccine Mandate Rules Have Been Drafted
Maine Health System News
•  Central Maine Healthcare Services, Staffing, Vaccine Mandate, CEO Appointment
Clinical News
•  New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke
•  Top JAMA, JAMA Network, and New England Journal of Medicine Articles
Physician Well Being
•  Using Electronic Health Records to Predict Physician Departure
Webinars
•  Preventing Stimulant Misuse Among College-Aged Students
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  SUPPORT for ME Training and Technical Assistance Initiative
•  SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1
•  Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)
•  Physician (BC/BE in Family Medicine) - Bingham Area Health Center

 

Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds

Planning is underway in anticipation of the Advisory Committee on Immunization Practices’ (ACIP) decision regarding Moderna booster vaccines. As we await ACIP’s decision next week, we are continuing to work on our planning and preparedness efforts ahead of the final decision.

 

Maine CDC is also preparing for the potential approval of an EUA for the Pfizer COVID-19 vaccine for youth ages 5-11 years old by outlining the key differences between the adult/adolescent formulation and the pediatric formulation.

Planning is underway in anticipation of the Advisory Committee on Immunization Practices’ (ACIP) decision regarding Moderna booster vaccines. As we await ACIP’s decision next week, we are continuing to work on our planning and preparedness efforts ahead of the final decision.

The proposed dosage size for Moderna’s booster dose is 0.25mL, which is half of the dosage size of the primary doses given. Please note that you will use a 1mL syringe to extract the 0.25mL booster dose.

Maine CDC is also preparing for the potential approval of an EUA for the Pfizer COVID-19 vaccine for youth ages 5-11 years old by outlining the key differences between the adult/adolescent formulation and the pediatric formulation.

Click here for Maine CDC’s message on Moderna boosters which includes the following guidance:

  • For Moderna vaccine currently in your inventory
  • For future vaccine orders after ACIP meets

Click here for the Maine CDC memo: Anticipated Emergency Use Authorization of Pfizer COVID-19 Vaccine for 5-11-year-olds.

Maine CDC will be communicating additional guidance as they receive it. over the next week. For any questions, please call the Maine Immunization Program at 207-287-3746